Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Leukemia

Free Subscription Articles published in Leuk Lymphoma Retrieve available abstracts of 343 articles: HTML format Text format

Single Articles

February 2012
1. ZHENG F , Li H, Li J, Du W, et al
   hERG1 K(+) channels regulated shedding of leukemia cell-derived microvesicles.
   Leuk Lymphoma. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   January 2012
2. PROCHOREC-SOBIESZEK M , Nasilowska-Adamska B, Borg K, Kopec I, et al
   Chronic eosinophilic leukemia with erythroblastic proliferation and the rare translocation t(8;9)(p22;p24) with PCM1-JAK2 fusion gene - a distinct clinical, pathological and genetic entity with potential treatment target?
   Leuk Lymphoma. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. WANG ES , Yee K, Koh LP, Hogge D, et al
   Phase 1 trial of linifanib (ABT-869) in patients with refractory or relapsed acute myeloid leukemia.
   Leuk Lymphoma. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. DE VIRON E , Michaux L, Put N, Bontemps F, et al
   Present status and perspectives in functional analysis of p53 in chronic lymphocytic leukemia.
   Leuk Lymphoma. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. DOUBEK M , Trbusek M, Malcikova J, Brychtova Y, et al
   Specific p53 mutations do not impact results of alemtuzumab therapy among chronic lymphocytic leukemia patients.
   Leuk Lymphoma. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
6. CHEN SH , Yang CP, Jaing TH, Hung IJ, et al
   The Clinical Impact of in vitro Cellular Drug Resistance on Childhood Acute Lymphoblastic Leukemia in Taiwan.
   Leuk Lymphoma. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. TSCHIEDEL S , Bach E, Jilo A, Wang SY, et al
   Bcr-Abl dependent post transcriptional activation of NME2 expression is a specific and common feature of chronic myeloid leukemia.
   Leuk Lymphoma. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. ZENTA C
   Improving Quality of Life in Chronic Lymphocytic Leukemia.
   Leuk Lymphoma. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
9. PERRY C , Herishanu Y, Hazan-Halevy I, Kay S, et al
   Reciprocal changes in regulatory T cells and Th17 helper cells induced by exercise in patients with chronic lymphocytic leukemia.
   Leuk Lymphoma. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
10. GOGIA A , Sharma A, Raina V, Gupta R, et al
    Priapism as an initial presentation of Chronic Lymphocytic Leukemia.
    Leuk Lymphoma. 2012.
    PubMed     Text format     Related articles   
    
    
    
    
11. SIMARA P , Peterkova M, Stejskal S, Potesilova M, et al
    BCR-ABL activity measured by the IC50(imatinib), p-CrkL/CrkL ratio, or p-CrkL ratio in CD34+ cells of chronic myeloid leukemia patients does not predict treatment response.
    Leuk Lymphoma. 2012.
    PubMed     Text format     Related articles   
    
    
    
    
12. LENGLINE E , Raffoux E, Lemiale V, Darmon M, et al
    ICU Management of Patients with Newly Diagnosed Acute Myeloid Leukemia with no Organ Failure.
    Leuk Lymphoma. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. KRASZEWSKA MD , Dawidowska M, Kosmalska M, Sedek L, et al
    Immunoglobulin/T-cell receptor gene rearrangements in the diagnostic paradigm of pediatric T-cell acute lymphoblastic leukemia patients.
    Leuk Lymphoma. 2012.
    PubMed     Text format     Related articles   
    
    
    
    
14. SELLMANN L , Carpinteiro A, Nuckel H, Scholtysik R, et al
    p53 protein expression in chronic lymphocytic leukemia.
    Leuk Lymphoma. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. ANSSTAS G , Vij R
    Evolution of definitions of response, progression-free survival, and event-free survival in front-line studies of chronic myeloid leukemia.
    Leuk Lymphoma. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. TONG N , Zhang L, Sheng X, Wang M, et al
    Functional polymorphisms in the FAS, FASL and CASP8 genes and risk of childhood acute lymphoblastic leukemia: a case-control study.
    Leuk Lymphoma. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. HAYASHI Y , Nakamae H, Katayama T, Nakane T, et al
    Different immunoprofiles in patients with chronic myeloid leukemia treated with imatinib, nilotinib or dasatinib.
    Leuk Lymphoma. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2011
18. DA SILVEIRA CA , Ferrari I
    First-line treatment with imatinib mesylate in chronic phase chronic myeloid leukemia patients: Experience of a public hospital in a developing country of South America.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
19. MIKESKA T , Carney DA, Seymour JF, Dobrovic A, et al
    No evidence for DNA methylation of the ATM promoter CpG island in chronic lymphocytic leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
20. TANTIWORAWIT A , Power MM, Barnett MJ, Hogge DE, et al
    Long-term Follow-up of Patients with Chronic Myeloid Leukemia in Chronic Phase Developing Sudden Blast Phase on Imatinib Therapy.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. WANG H , Geng QR, Wang L, Lu Y, et al
    Curcumin potentiates antitumor activity of L-asparaginase via inhibition of AKT signaling pathway in acute lymphoblastic leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. AOKI J , Ohashi K, Kobayashi T, Kakihana K, et al
    Sustained complete molecular response of chronic myeloid leukemia after discontinuation of second-generation tyrosine kinase inhibitors.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
23. ELSE M , Cocks K, Crofts S, Wade R, et al
    Quality of life in chronic lymphocytic leukemia: 5-year results from the multicenter randomized LRF CLL4 trial.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. JONES JA , Kraut EH, Deam D, Byrd JC, et al
    Hematologic improvement after flavopiridol treatment of pentostatin and rituximab refractory hairy cell leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
25. DE BRAEKELEER E , Douet-Guilbert N, Meyer C, van Deventer FM, et al
    MLL-ELL fusion gene in 2 infants with acute monoblastic leukemia and myeloid sarcoma.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
26. FOSTER MC , Amin C, Voorhees PM, van Deventer HW, et al
    A Phase I, Dose Escalation Study of Clofarabine in Combination with Fractionated Gemtuzumab Ozogamicin in Patients with Refractory or Relapsed Acute Myeloid Leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. TIU R , Kalaycio M
    Targeted Therapy for Patients with Chronic Myeloid Leukemia: Clinical Trial Experience and Challenges in Intertrial Comparisons.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. CANNAS G , Pautas C, Raffoux E, Quesnel B, et al
    Infectious complications in adult acute myeloid leukemia: Analysis of the prospective multicenter clinical trial ALFA-9802.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. ZHOU K , Yi S, Yu Z, Li Z, et al
    microRNA-223 expression is uniformly down-regulated in B cell lymphoproliferative disorders and is associated with poor survival in chronic lymphocytic leukemia patients.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. F SEYMOUR J
    Osteolytic bone lesions in non-transformed chronic lymphocytic leukemia are not as rare as suggested.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
31. KRISTENSEN T , Preiss B, Broesby-Olsen S, Vestergaard H, et al
    Systemic mastocytosis uncommon in KIT D816V mutation positive core-binding factor acute myeloid leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. TAN AY , Wong SQ, Nyvold CG, Carney DA, et al
    Rapid detection of FLT3 exon 20 tyrosine kinase domain mutations in patients with acute myeloid leukemia by high-resolution melting (HRM) analysis.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
33. JAKOVLJEVIC K , Malisic E, Cavic M, Radulovic S, et al
    Association between the methylenetetrahydrofolate reductase polymorphism (MTHFR C677T) and risk of chronic myeloid leukemia in Serbian population.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
34. ZHONG Y , Wu J, Chen B, Ma R, et al
    Investigation and analysis of single nucleotide polymorphisms in the Janus kinase (JAK) / signal transducer and activator of transcription (STAT) genes with leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. LAFEUILLE MH , Vekeman F, Wang ST, Kerrigan M, et al
    Lifetime Costs to Medicare of Providing Care to Patients with Chronic Lymphocytic Leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. LANE S , Gill D, McMillan NA, Saunders N, et al
    Valproic acid combined with cytosine arabinoside in elderly patients with acute myeloid leukemia has in vitro but limited clinical activity.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. QIAN X , Cao S, Yang G, Dong J, et al
    Variant Genotypes of MDR1 C3435T Increase the Risk of Leukemia: Evidence from 10 case-control studies.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. SKAFF ER , Doucette S, McDiarmid S, Huebsch L, et al
    Vascular Access Devices in Leukemia: A Retrospective Review amongst Patients Treated at the Ottawa Hospital with Induction Chemotherapy for Acute Leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. ER ULJ N , Kotnik BF, Debeljak MA, Jazbec J, et al
    The Influence of Folate Pathway Polymorphisms on High-Dose Methotrexate-Related Toxicity and Survival in Childhood Acute Lymphoblastic Leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. GUTMAN JA , Hoffner B
    A Novel CEBPA Germline Variant in a Case of Acute Myeloid Leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
41. BLANCO E , Beyene J, Maloney AM, Almeida R, et al
    Non-Relapse Mortality in Pediatric Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. NABHAN C , Tolentino A, Meyer A, Tallman MS, et al
    Cutaneous Involvement with B-Lineage Acute Lymphoblastic Leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
43. LI YF , Deng Z, Din BH, Zhu JB, et al
    The effect of Homoharringtonine on bone marrow CD34+CD117 + cells in patients with chronic myelogenous leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. ROLLIG C , Brandts C, Shaid S, Hentrich M, et al
    Survey and analysis of the efficacy and prescription pattern of sorafenib in patients with acute myeloid leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
45. GANZEL C , Gatt ME, Maly A, Ben-Yehuda D, et al
    High incidence of skin rash in patients with hairy cell leukemia treated with cladribine.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. QIAO C , Zhang R, Hong M, Wang L, et al
    Heterogeneous leukemic clones identified by NPM1 mutation analysis in patient with acute monocytic leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. KELEMEN K , Kovacsovics T, Corless C, Beadling C, et al
    RAS mutations in therapy-related acute myeloid leukemia after successful treatment of acute promyelocytic leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
48. HUANG PY , Giles Best O, Belov L, Mulligan SP, et al
    Surface profiles for sub-classification of chronic lymphocytic leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. NICOLINI FE , Masszi T, Shen Z, Gallagher NJ, et al
    Expanding nilotinib access in clinical trials (ENACT), an open-label, multicenter study of oral nilotinib in adult patients with imatinib-resistant or -intolerant chronic myeloid leukemia in the accelerated phase or blast crisis.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. SEIFFERT M , Dietrich S, Jethwa A, Glimm H, et al
    Exploiting biological diversity and genomic aberrations in chronic lymphocytic leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. LIFFRAUD C , Quillet-Mary A, Fournie JJ, Laurent G, et al
    Protein Phosphatase-2A activation is a critical step for enzastaurin activity in Chronic Lymphoid Leukemia cells.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. EOM KS , Kim HJ, Cho BS, Choi SM, et al
    Hematopoietic stem cell transplant following remission induction chemotherapy including gemtuzumab ozogamicin is a feasible and effective treatment option in elderly patients with acute myeloid leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. LEPRETRE S , Jager U, Janssens A, Leblond V, et al
    The value of rituximab for the treatment of fludarabine-refractory chronic lymphocytic leukemia: A systematic review and qualitative analysis of the literature.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. SURAPOLCHAI P , Pakakasama S, Sirachainan N, Anurathapan U, et al
    Comparative Outcomes of Thai Children with Acute Lymphoblastic Leukemia Treated with 2 Consecutive Protocols: 11-year Experience.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. REZA S , Ling Z
    Secondary T-lymphoblastic leukemia in a patient with hairy cell leukemia following cladribine therapy: report of an extremely rare case and review of the literature.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
56. HUANG L , Huang J, Wu P, Li Q, et al
    Association of genetic variations in mTOR with risk of childhood acute lymphoblastic leukemia in a Chinese population.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. MIGLINO M , Colombo N, Pica G, Grasso R, et al
    WT1 overexpression at diagnosis may predict favorable outcome in patients with de novo non-M3 acute myeloid leukemia.
    Leuk Lymphoma. 2011;52:1961-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
58. CHEN M , de Carvalho Bittencourt M, Feugier P, Faure GC, et al
    Active Toll-Like Receptor-7 triggering of chronic lymphocytic leukemia B-cells by Imiquimod.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
59. AU WING Y , Wan Thomas SK, Leung Rock YY, Lie Albert KW, et al
    Sequential chronic myelogenous leukemia, B-lineage lymphoma and erythroleukemia with monosomy 7 over ten years.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
60. CANNELLA L , Loglisci G, Nanni M, De Cuia MR, et al
    Trisomy 8 in Philadelphia chromosome negative cell preceding the evolution of a Philadelphia chromosome positive clone with the same additional change during imatinib treatment: revisiting the role of genetic instability in chronic myeloid leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
61. TAVIL B , Balta G, Ergun EL, Ozkasap S, et al
    Leptin promoter G-2548A genotypes and associated serum leptin levels in childhood acute leukemia at diagnosis and under high dose steroid therapy.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. EVANS MW , Sung AD, Gojo I, Tidwell M, et al
    Risk assessment in human immunodeficiency virus-associated acute myeloid leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. KIM HN , Kim NY, Yu L, Tran HT, et al
    The association GSTT1 polymorphisms with acute myeloid leukemia risk is dependent of smoking status.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. LANASA MC , Davis PH, Datto M, Li Z, et al
    Phase II study of cenersen, an antisense inhibitor of p53, in combination with fludarabine, cyclophosphamide and rituximab for high-risk chronic lymphocytic leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. AHMAD FA , Drummond MW
    Reversible nicorandil induced perianal ulceration in acute myeloid leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
66. DROST AC , Seitz G, Boehmler A, Funk M, et al
    The G Protein-coupled Receptor CysLT1 Mediates Chemokine-like Effects and Prolongs Survival in Chronic Lymphocytic Leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. WU YJ , Zhu Y, Qian SX, Wang L, et al
    Detection of BCR-ABL fusion proteins in patients with leukemia using a cytometric bead array.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. GRITTI G , Reda G, Maura F, Piciocchi A, et al
    Low dose alemtuzumab in fludarabine-refractory chronic lymphocytic leukemia patients.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. FRIDAY E , Koshy N, Bhanderi V, Turturro F, et al
    Thioredoxin-interacting protein (TXNIP) and chronic lymphocytic leukemia (CLL).
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
70. LARSON SM , Campbell NP, Huo D, Artz A, et al
    High Dose Cytarabine and Mitoxantrone: An Effective Induction Regimen for High-Risk Acute Myeloid Leukemia (AML).
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. NEOKLEOUS N , Seimeni O, Koumas S, Prokopiou C, et al
    Mercaptopurine-induced hypersensitivity febrile reaction in patient with acute promyelocytic leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
72. ERBILGIN Y , Ng OH, Mavi N, Ozbek U, et al
    Genetic Alterations in the Members of WNT Pathway in Acute Leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
73. TAM CS , Gandhi V
    Modifying the Immune System to Treat Chronic Lymphocytic Leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
74. ZANROSSO CW , Emerenciano M, Faro A, de Aguiar Goncalves BA, et al
    Genetic variability in N-Acetyltransferase 2 gene determines susceptibility to childhood lymphoid or myeloid leukemia in Brazil.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
75. WENDTNER CM , Hillmen P, Mahadevan D, Buhler A, et al
    Final results of a multicenter phase 1 study of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. CLAXTON D , Erba HP, Faderl S, Arellano M, et al
    Outpatient Consolidation Treatment with Clofarabine in a Phase 2 Study of Older Adult Patients with Previously Untreated Acute Myelogenous Leukemia (AML).
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. MARQUEZ ME , Deglesne PA, Lopez JL, Da Costa O, et al
    Unexpectedly High Frequency of European Parentage in Venezuelan Patients with Chronic Lymphocytic Leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. YANG L , Yu Y, Kang R, Yang M, et al
    Up-regulated autophagy by endogenous HMGB1 promotes chemoresistance in leukemia cells.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. BONN BR , Krieger D, Burkhardt B
    Cell Cycle Regulatory Molecular Profiles of Pediatric T-Cell Lymphoblastic Leukemia and Lymphoma.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. VAN DEN NESTE E , Letestu R, Aurran-Schleinitz T, Ysebaert L, et al
    Post-remission intervention with alemtuzumab or rituximab to eradicate minimal residual disease in chronic lymphocytic leukemia: where do we stand?
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. NISHIWAKI S , Miyamura K
    Allogeneic Stem Cell Transplantation For Adult Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. ABU-GHANEM S , Rabinovich A, Delgado B, Benharroch D, et al
    Chronic myelogenous leukemia diagnosed in two patients with breast cancer.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
83. GLADSTONE DE , Swinnen L, Kasamon Y, Blackford A, et al
    Importance of immunoglobulin heavy chain variable region mutational status in del(13q) chronic lymphocytic leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. NEY-GARCIA D , Liehr T, Bhatt S, de Souza M, et al
    Molecular cytogenetic studies reveal an unexpected chromosomal inversion as a variant of t(12;21)(p13;q22) in a child with B-cell precursor acute lymphoblastic leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
85. YUAN C , Zhang YS, Cheng YN, Xue X, et al
    A112, a tamibarotene dimethylaminoethyl ester, may inhibit human leukemia cell growth more potently than tamibarotene.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
86. BROWN T , Swansbury J, Taj MM
    Prognosis of patients with t(8;16)(p11;p13) Acute Myeloid Leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
87. ARISTEGUIETA C
    Three cases of hairy-cell leukemia in coal miners.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
88. HORNBERGER J , Reyes C, Shewade A, Lerner S, et al
    Cost-effectiveness of adding rituximab to fludarabine and cyclophosphamide for the treatment of previously untreated chronic lymphocytic leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. GAILLARD JB , Chiesa J, Reboul D, Arnaud A, et al
    Monosomal karyotype defines routinely a poor prognosis subgroup in acute myeloid leukemia and is frequently associated with TP53 deletion - Letter to the editor.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
90. HAYDEN RE , Pratt G, Roberts C, Drayson MT, et al
    Treatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approaches.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
91. ZENT CS , Smith BJ, Ballas ZK, Wooldridge JE, et al
    A Phase I Clinical Trial of CpG Oligonucleotide 7909 (PF-03512676) in Patients with Previously Treated Chronic Lymphocytic Leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
92. T H , T S, R E, C T, et al
    Progressive multifocal leukoencephalopathy after treatment with rituximab, fludarabine and cyclophosphamide in a patient with chronic lymphocytic leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
93. CAMGOZ A , Gencer EB, Ural AU, Avcu F, et al
    Roles of ceramide synthase and ceramide clearence genes in nilotinib-induced cell death in chronic myeloid leukemia cells.
    Leuk Lymphoma. 2011;52:1574-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
94. WANG Y , Chen G, Qiao S, Ma X, et al
    Keratinocyte growth factor enhanced immune reconstitution in murine allogeneic umbilical cord blood cell transplant.
    Leuk Lymphoma. 2011;52:1556-66.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
95. AL-NAWAKIL C , Kosmider O, Stern MH, Manie E, et al
    Leukemic phase of follicular lymphomas: an atypical presentation.
    Leuk Lymphoma. 2011;52:1504-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
96. LIU CJ , Hong YC, Yang CF, Liu SH, et al
    Clinicopathologic features and outcome of acute erythroid leukemia - based on the 2008 revised WHO classification.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
97. NOSARI A , Caimi TM, Zilioli V, Molteni A, et al
    Cerebral Hemorrhage Treated with Novoseven in Acute Promyelocytic Leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
98. BIOJONE E , de Paula Queiroz R, Valera ET, Odashima NS, et al
    Minimal Residual Disease in Cerebrospinal Fluid at Diagnosis: A More Intensive Treatment Protocol Was Able to Eliminate the Adverse Prognosis in Children with Acute Lymphoblastic Leukemia.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
99. GIUDICE ID , Mauro FR, Foa R
    Chronic lymphocytic leukemia in less fit patients ("SLOW-GO").
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
100. FRANCESCO C , Lara R, Olga S, Giulia D, et al
     Clonal Evolution including 14q32/IGH translocations in Chronic Lymphocytic Leukemia: analysis of clinicobiologic correlations in 105 patients.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
101. AL-ALI HK , Jaekel N, Junghanss C, Maschmeyer G, et al
     Azacitidine in patients with acute myeloid leukemia medically unfit for or resistant to chemotherapy: a multicenter phase I/II study.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
102. YAKIMCHUK K , Norin S, Kimby E, Hagglund H, et al
     Upregulated estrogen receptor beta2 in chronic lymphocytic leukemia.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
103. GERRIE A , Toze C, Ramadan K, Li C, et al
     Oral fludarabine and rituximab as initial therapy for chronic lymphocytic leukemia or small lymphocytic lymphoma: population-based experience matches clinical trials.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
104. LI W , Frame LT, Hoo KA, Li Y, et al
     Genistein inhibited proliferation and induced apoptosis in acute lymphoblastic leukemia, lymphoma and multiple myeloma cells in vitro.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
105. ANGELOVA S , Zechev J, Stoimenov A, Spassov B, et al
     A novel t(7;21)(q32;q22) translocation disrupting the RUNX1 gene in an adult patient with acute myeloid leukemia.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
106. WATTERS RJ , Liu X, Loughran TP
     T-cell and natural killer-cell large granular lymphocyte leukemia neoplasias.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
107. MARTI GE , Stetler-Stevenson M, Grant ND, White T, et al
     Phase I trial of 7-hydroxystaurosporine and fludararbine phosphate: in vivo evidence of 7-hydroxystaurosporine induced apoptosis in chronic lymphocytic leukemia.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
108. MALAGOLA M , Skert C, Vignetti M, Piciocchi A, et al
     A simple prognostic scoring system for newly diagnosed cytogenetically normal acute myeloid leukemia: retrospective analysis of 530 patients.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
109. HU X , Xu J, Sun A, Shen Y, et al
     Successful T-cell acute lymphoblastic leukemia treatment with proteasome inhibitor bortezomib based on evaluation of nuclear factor-?B activity.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
110. YONG W , Ping C, Hui-Fang H, Mei-Juan H, et al
     Reduction of TGF-?1 expression in leukemia cells from acute leukemia patients and its role in leukemia development.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
111. SHEN M , Bunaciu RP, Congleton J, Jensen HA, et al
     The interferon regulatory factor-1 binds c-Cbl, enhances MAPK signaling and promotes retinoic acid-induced differentiation of HL-60 human myelo-monoblastic leukemia cells.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
112. WANG ES , Zeidan A, Tan W, Wilding GE, et al
     Cytoreduction with gemtuzumab ozogamicin and cytarabine prior to allogeneic stem cell transplantation for relapsed/refractory acute myeloid leukemia.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
113. ZENT CS
     Multi-parameter prognostication in chronic lymphocytic leukemia.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
114. SPINA F , Alessandrino PE, Milani R, Bonifazi F, et al
     Allogeneic Stem Cell Transplantation in Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndromes: Impact of Patient Characteristics and Timing of Transplant.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
115. NELSON DM , Joseph B, Hillion J, Segal J, et al
     Flavopiridol induces BCL-2 expression and represses oncogenic transcription factors in leukemic blasts from adults with refractory acute myeloid leukemia.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
116. YSEBAERT L , Fournie JJ
     Genomic and phenotypic characterization of nurse-like cells that promote drug resistance in chronic lymphocytic leukemia.
     Leuk Lymphoma. 2011;52:1404-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
117. MICHALLET AS , Rossignol J, Cazin B, Ysebaert L, et al
     Rituximab-cyclophosphamide-dexamethasone combination in management of autoimmune cytopenias associated with chronic lymphocytic leukemia.
     Leuk Lymphoma. 2011;52:1401-3.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
118. LANASA MC , Weinberg JB
     Immunoglobulin class switch recombination in chronic lymphocytic leukemia.
     Leuk Lymphoma. 2011;52:1398-400.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
119. ANTIC D , Mihaljevic B, Cokic V, Fekete MD, et al
     Patients with early stage chronic lymphocytic leukemia: new risk stratification based on molecular profiling.
     Leuk Lymphoma. 2011;52:1394-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
120. FISCHER K , Shanafelt T, Kater AP
     Highlights of the 5th Young Investigators' Meeting on chronic lymphocytic leukemia.
     Leuk Lymphoma. 2011;52:1391-3.
     PubMed     Text format     Related articles   
     
     
     
     
121. XIAO W , Ishdorj G, Sun J, Johnston JB, et al
     Death receptor 4 is preferentially recruited to lipid rafts in chronic lymphocytic leukemia cells contributing to tumor necrosis related apoptosis inducing ligand-induced synergistic apoptotic responses.
     Leuk Lymphoma. 2011;52:1290-301.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
122. ROSS DM , Branford S
     Minimal residual disease: the advantages of digital over analog polymerase chain reaction.
     Leuk Lymphoma. 2011;52:1161-3.
     PubMed     Text format     Related articles   
     
     
     
     
123. HU M , Liu Y, Deng C, Han R, et al
     Enhanced invasiveness in multidrug resistant leukemic cells is associated with overexpression of P-glycoprotein and cellular inhibitor of apoptosis protein.
     Leuk Lymphoma. 2011;52:1302-11.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
124. TIBES R , Mesa RA
     Myeloproliferative neoplasms 5 years after discovery of JAK2V617F: what is the impact of JAK2 inhibitor therapy?
     Leuk Lymphoma. 2011;52:1178-87.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     June 2011
125. TANG C , Schafranek L, Watkins DB, Parker WT, et al
     Tyrosine kinase inhibitor resistance in chronic myeloid leukemia cell lines: investigating resistance pathways.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
126. SUBRAMANIYAM S , Fraser CR, Rao PH, Feldman E, et al
     De novo B lymphoblastic leukemia/lymphoma in an adult with t(14;18)(q32;q21) and c-MYC gene rearrangement involving 10p13.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
127. LU CM , Zhou L, Feng S, Kohn PH, et al
     Presence of complex t(6;9;22;15) four-way chromosome rearrangement plus rare t(1;6) translocation with favorable response to imatinib therapy in chronic myelogenous leukemia.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
128. BEZARES RF , Stemelin G, Diaz A, Argentieri D, et al
     Multicenter study of subcutaneous alemtuzumab administered at reduced dose in patients with fludarabine-relapsed/refractory chronic lymphocytic leukemia: final analysis.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
129. CARGO CA , Westerman DA, Gambell P, Juneja S, et al
     Flow-cytometric minimal residual disease monitoring for chronic lymphocytic leukemia in the post-allogeneic transplant period.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
130. MCNEER JL
     The complex interplay between folate metabolism and risk of acute lymphoblastic leukemia.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
131. FERRER G , Hodgson K, Pereira A, Juan M, et al
     Combined analysis of levels of serum B-cell activating factor and a proliferation-inducing ligand as predictor of disease progression in patients with chronic lymphocytic leukemia.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
132. TONG N , Sheng X, Wang M, Fang Y, et al
     Methylenetetrahydrofolate reductase gene polymorphisms and acute lymphoblastic leukemia risk: a meta-analysis based on 28case-control studies.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
133. WILHELM C , Neubauer A, Burchert A
     Poor-risk cytogenetics may be associated with inferior outcome after fludarabine, cytarabine, and amsacrine reduced intensity conditioning in patients with high-risk acute myeloid leukemia.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
134. KATZ BZ , Polliack A
     Cancer microenvironment, extracellular matrix, and adhesion molecules: the bitter taste of sugars in chronic lymphocytic leukemia.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
135. ALDANA-MASANGKAY GI , Rodriguez-Gonzalez A, Lin T, Ikeda AK, et al
     Tubacin suppresses proliferation and induces apoptosis of acute lymphoblastic leukemia cells.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
136. JULIUSSON G , Tadmor T, Polliack A
     'Hairy' cells: where are the roots of this leukemia?
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
137. BENGIO RM , Riva ME, Moiraghi B, Lanari E, et al
     Clinical outcome of chronic myeloid leukemia imatinib-resistant patients: do BCR-ABL kinase domain mutations affect patient survival? First multicenter Argentinean study.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
138. FEDELE R , Martino M, Dattola A, Cuzzola M, et al
     Imatinib mesylate in T-cell large granular lymphocyte leukemia associated with chronic graft-versus-host disease.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
139. FLOISAND Y , Delabie J, Fossa A, Helseth E, et al
     Richter syndrome presenting as a solitary cerebellar tumor during first-line treatment for chronic lymphocytic leukemia.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
140. YANG L , Liu L, Wang J, Qiu L, et al
     Polymorphisms in folate-related genes: impact on risk of adult acute lymphoblastic leukemia rather than pediatric in Han Chinese.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
141. BRIOLI A , Parisi S, Iacobucci I, Cavo M, et al
     Patient with ataxia telangiectasia who developed acute myeloid leukemia.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
142. EKLUND EA , Platanias LC
     Inhibition of histone deacetylase 6 as a therapeutic strategy for acute lymphocytic leukemia.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
143. HIGUCHI T , Yamazoe M, Yamaguchi N, Okada S, et al
     Hemophagocytic lymphohistiocytosis following differentiation syndrome in acute promyelocytic leukemia.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
144. FARIA DE FIGUEIREDO A , Liehr T, Bhatt S, Binato R, et al
     A complex karyotype masked a cryptic variant t(8;21)(q22;q22) in a child with acute myeloid leukemia.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
145. HIRABAYASHI K , Shiohara M, Takahashi D, Saito S, et al
     Retrospective analysis of risk factors for development of liver dysfunction in transient leukemia of Down syndrome.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
146. ZENT CS , Kay NE
     Management of patients with chronic lymphocytic leukemia with a high risk of adverse outcome: the Mayo Clinic approach.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
147. RIVIER A , Perny J, Debourgogne A, Thivillier C, et al
     Fatal disseminated infection due to Scedosporium prolificans in a patient with acute myeloid leukemia and posaconazole prophylaxis.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
148. KATSIBARDI K , Braoudaki M, Papathanasiou C, Karamolegou K, et al
     Clinical significance of productive immunoglobulin heavy chain gene rearrangements in childhood acute lymphoblastic leukemia.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
149. HERISHANU Y , Gibellini F, Njuguna N, Hazan-Halevy I, et al
     Activation of CD44, a receptor for extracellular matrix components, protects chronic lymphocytic leukemia cells from spontaneous and drug induced apoptosis through MCL-1.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
150. KAYAL S , Singhal B, Thulkar S, Mishra J, et al
     Acute Budd-Chiari syndrome in pediatric acute promyelocytic leukemia.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
151. FORGHIERI F , Morselli M, Potenza L, Maccaferri M, et al
     A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
152. HAUSSEN DC , Macedo FY, Caperton CV, Zuckerman DC, et al
     Clostridium subterminale sepsis in adult acute lymphoblastic leukemia.
     Leuk Lymphoma. 2011;52:1137-8.
     PubMed     Text format     Related articles   
     
     
     
     
153. HASEGAWA H , Komoda M, Yamada Y, Yonezawa S, et al
     Aberrant overexpression of membrane-associated mucin contributes to tumor progression in adult T-cell leukemia/lymphoma cells.
     Leuk Lymphoma. 2011;52:1108-17.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
154. PILECKYTE R , Jurgutis M, Valceckiene V, Stoskus M, et al
     Dose-dense high-dose methylprednisolone and rituximab in the treatment of relapsed or refractory high-risk chronic lymphocytic leukemia.
     Leuk Lymphoma. 2011;52:1055-65.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
155. RUND D
     Genotyping chronic lymphocytic leukemia in China: East meets West.
     Leuk Lymphoma. 2011;52:941-2.
     PubMed     Text format     Related articles   
     
     
     
     
156. KREITMAN RJ , Polliack A, Grever M
     Treatment of hairy cell leukemia in its second half-century: an international conference on hairy cell leukemia at the National Institutes of Health, April 26-27, 2010, Bethesda, MD.
     Leuk Lymphoma. 2011;52 Suppl 2:1-2.
     PubMed     Text format     Related articles   
     
     
     
     
157. NOEL P
     Definition of remission, minimal residual disease, and relapse in hairy cell leukemia bone marrow biopsy histology and immunohistology specimens.
     Leuk Lymphoma. 2011;52 Suppl 2:62-4.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
158. ARONS E , Kreitman RJ
     Molecular variant of hairy cell leukemia with poor prognosis.
     Leuk Lymphoma. 2011;52 Suppl 2:99-102.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
159. KREITMAN RJ , Arons E, Stetler-Stevenson M, Fitzgerald DJ, et al
     Recombinant immunotoxins and other therapies for relapsed/refractory hairy cell leukemia.
     Leuk Lymphoma. 2011;52 Suppl 2:82-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
160. TADMOR T , Polliack A
     Unusual clinical manifestations, rare sites of involvement, and the association of other disorders with hairy cell leukemia.
     Leuk Lymphoma. 2011;52 Suppl 2:57-61.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
161. ROBAK T
     Management of hairy cell leukemia variant.
     Leuk Lymphoma. 2011;52 Suppl 2:53-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
162. JULIUSSON G , Samuelsson H
     Hairy cell leukemia: epidemiology, pharmacokinetics of cladribine, and long-term follow-up of subcutaneous therapy.
     Leuk Lymphoma. 2011;52 Suppl 2:46-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
163. GREVER MR
     Hairy cell leukemia: a successful model for experimental therapeutics--pentostatin and new ideas.
     Leuk Lymphoma. 2011;52 Suppl 2:25-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
164. DEARDEN CE , Else M, Catovsky D
     Long-term results for pentostatin and cladribine treatment of hairy cell leukemia.
     Leuk Lymphoma. 2011;52 Suppl 2:21-4.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
165. HABERMANN TM , Rai K
     Historical treatments of in hairy cell leukemia, splenectomy and interferon: past and current uses.
     Leuk Lymphoma. 2011;52 Suppl 2:18-20.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
166. POLLIACK A , Tadmor T
     Surface topography of hairy cell leukemia cells compared to other leukemias as seen by scanning electron microscopy.
     Leuk Lymphoma. 2011;52 Suppl 2:14-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
167. GOLOMB HM
     Fifty years of hairy cell leukemia treatments.
     Leuk Lymphoma. 2011;52 Suppl 2:3-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
168. FITZGERALD DJ , Moskatel E, Ben-Josef G, Traini R, et al
     Enhancing immunotoxin cell-killing activity via combination therapy with ABT-737.
     Leuk Lymphoma. 2011;52 Suppl 2:79-81.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
169. STONE EJ
     A patient's point of view.
     Leuk Lymphoma. 2011;52 Suppl 2:108-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
170. PASTAN I , Onda M, Weldon J, Fitzgerald D, et al
     Immunotoxins with decreased immunogenicity and improved activity.
     Leuk Lymphoma. 2011;52 Suppl 2:87-90.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
171. LAURIA F , Cencini E, Forconi F
     Alternative methods of cladribine administration.
     Leuk Lymphoma. 2011;52 Suppl 2:34-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
172. VIGIL C , Block AW, Wetzler M
     The significance of quantifiable residual normal karyotype hematopoietic cells for toxicity and outcome.
     Leuk Lymphoma. 2011;52:943.
     PubMed     Text format     Related articles   
     
     
     
     
173. ABBOTT IJ , Slavin MA
     Anaerobes: not to be forgotten in neutropenic fever.
     Leuk Lymphoma. 2011;52:948-9.
     PubMed     Text format     Related articles   
     
     
     
     
174. NEGAARD HF , Sandset PM, Kolset SO, Svennevig K, et al
     Associations between regulators of extracellular matrix and hemostatic factors in hematologic neoplasias.
     Leuk Lymphoma. 2011;52:1157-9.
     PubMed     Text format     Related articles   
     
     
     
     May 2011
175. BASSAN R
     Optimal central nervous system prophylaxis in Philadelphia chromosome-positive acute lymphoblastic leukemia: collateral damage in the imatinib era?
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
176. TADMOR T
     Alemtuzumab (Campath-1H) for chronic lymphocytic leukemia: a drug in search of its optimal schedule.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
177. RIERA L , Lasorsa E, Bonello L, Sismondi F, et al
     Description of a novel Janus kinase 3 P132A mutation in acute megakaryoblastic leukemia and demonstration of previously reported Janus kinase 3 mutations in normal subjects.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
178. TRELINSKA J , Fendler W, Szadkowska A, Czerwoniuk D, et al
     Hypoglycemia and glycemic variability among children with acute lymphoblastic leukemia during maintenance therapy.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
179. KANELLIS G , Garcia-Alonso L, Camacho FI, Garcia JF, et al
     Hairy cell leukemia, blastic type: description of spleen morphology and immunophenotype of a distinctive case.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
180. FELICE MS , Gallego MS, Alonso CN, Alfaro EM, et al
     Prognostic impact of t(1;19)/ TCF3-PBX1 in childhood acute lymphoblastic leukemia in the context of Berlin-Frankfurt-Munster-based protocols.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
181. PATEL SB , Gojo I, Tidwell ML, Sausville EA, et al
     Subdural hematomas in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving imatinib mesylate in conjunction with systemic and intrathecal chemotherapy.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
182. AZIZ Z , Iqbal J, Aaqib M, Akram M, et al
     Assessment of quality of life with imatinib mesylate as first-line treatment in chronic phase-chronic myeloid leukemia.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
183. ZENT CS , Polliack A, Tadmor T
     FISHing for answers in proliferation centers of chronic lymphocytic leukemia lymph nodes.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
184. LI XY , Li Y, Zhang Y, Wang K, et al
     A novel bisindolymaleimide derivative (WK234) inhibits proliferation and induces apoptosis through the protein kinase Cbeta pathway, in chronic myelogenous leukemia K562 cells.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
185. LIU SG , Li ZG, Cui L, Gao C, et al
     Effects of methylenetetrahydrofolate reductase gene polymorphisms on toxicities during consolidation therapy in pediatric acute lymphoblastic leukemia in a Chinese population.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
186. BITETTO AM , Lamba G, Cadavid G, Shah D, et al
     Colonic perforation secondary to chronic lymphocytic leukemia infiltration without Richter transformation.
     Leuk Lymphoma. 2011;52:930-3.
     PubMed     Text format     Related articles   
     
     
     
     
187. AHMAD F , D'Souza W, Mandava S, Ranjan Das B, et al
     Molecular analysis of WT1 and KIT mutations in patients from an Indian population with de novo acute myeloid leukemia: determination of incidence, distribution patterns, and report of a novel KIT mutation.
     Leuk Lymphoma. 2011;52:865-76.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
188. MARIC I , Calvo KR
     Mastocytosis: the new differential diagnosis of CD30-positive neoplasms.
     Leuk Lymphoma. 2011;52:732-3.
     PubMed     Text format     Related articles   
     
     
     
     April 2011
189. LIMA LM , Sampat K, Assouline S, Saxe D, et al
     Does pretreatment fluorescence in situ hybridization for BCR-ABL predict imatinib-associated hematologic toxicity in chronic myeloid leukemia?
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
190. TORREY ML , Sigal DS, Saven A
     Development of cladribine at Scripps for hairy cell leukemia and current results.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
191. STETLER-STEVENSON M , Tembhare PR
     Diagnosis of hairy cell leukemia by flow cytometry.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
192. FORCONI F , Cencini E, Sozzi E, Sicuranza A, et al
     Insight into the behavior of hairy cell leukemia by immunogenetic analysis.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
193. CAWLEY JC
     Hairy cell leukemia and the microenvironment.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
194. ELSE M , Dearden CE, Matutes E, Forconi F, et al
     Rituximab with pentostatin or cladribine: an effective combination treatment for hairy cell leukemia after disease recurrence.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
195. KRAUT E
     Infectious complications in hairy cell leukemia.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
196. KREITMAN RJ , Polliack A, Grever M
     Treatment of Hairy Cell Leukemia in its Second Half-Century: An International Conference on Hairy Cell Leukemia at the National Institutes of Health, April 26-27, 2010, Bethesda, MD.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
197. CANALLE R , Silveira VS, Alberto Scrideli C, Queiroz RG, et al
     Impact of thymidylate synthase promoter and DNA repair gene polymorphisms on susceptibility to childhood acute lymphoblastic leukemia.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
198. KREITMAN RJ , Arons E, Stetler-Stevenson M, Miller KB, et al
     Response of hairy cell leukemia to bendamustine.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
199. GUO D , Teng Q, Ji C
     NOTCH and phosphatidylinositide 3-kinase/phosphatase and tensin homolog deleted on chromosome ten/AKT/mammalian target of rapamycin (mTOR) signaling in T-cell development and T-cell acute lymphoblastic leukemia.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
200. UDDIN S , Al-Kuraya KS
     Localization of death receptor 4 in lipid rafts sensitizes chronic lymphocytic leukemia to chemotherapeutic drug mediated apoptosis.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
201. TADMOR T
     Purine analog toxicity in patients with hairy cell leukemia.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
202. NOEL P
     Definition of remission, minimal residual disease, and relapse in hairy cell leukemia bone marrow biopsy histology and immunohistology specimens.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
203. AMREIN PC
     The potential for dasatinib in treating chronic lymphocytic leukemia, acute myeloid leukemia, and myeloproliferative neoplasms.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
204. TALLMAN MS
     Implications of minimal residual disease in hairy cell leukemia after cladribine using immunohistochemistry and immunophenotyping.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
205. DONG HJ , Miao KR, Qiao C, Zhuang Y, et al
     Polymorphisms and haplotypes in multidrug resistance 1 gene are not associated with chronic lymphocytic leukemia susceptibility and prognostic parameters of chronic lymphocytic leukemia in Chinese population.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
206. BOHM A , Herrmann H, Mitterbauer-Hohendanner G, Hauswirth AW, et al
     Stable non-transforming minimal residual disease in Philadelphia chromosome positive acute lymphoblastic leukemia after autologous transplantation: origin from neoplastic yet 'pre-leukemic' stem cells?
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
207. LOGLISCI G , Breccia M, Nanni M, Mancini M, et al
     Isodicentric duplication of Philadelphia chromosome as a mechanism of resistance to dasatinib in a patient with chronic myeloid leukemia after resistance to imatinib.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
208. JANIK JE
     Tumor markers in hairy cell leukemia.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
209. JOHNSTON JB
     Mechanism of Action of Pentostatin and Cladribine in Hairy Cell Leukemia.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
210. SOHN SK , Oh SJ, Kim BS, Ryoo HM, et al
     Trough plasma imatinib levels are correlated with optimal cytogenetic responses at 6 months after treatment with standard dose of imatinib in newly diagnosed chronic myeloid leukemia.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
211. GLINIANAIA SV , Pearce MS, Rankin J, Pless-Mulloli T, et al
     Birth weight by gestational age and risk of childhood acute leukemia: a population-based study 1961-2002.
     Leuk Lymphoma. 2011;52:709-12.
     PubMed     Text format     Related articles   
     
     
     
     
212. ROLLAND D , Bouamrani A, Houlgatte R, Barbarat A, et al
     Identification of proteomic signatures of mantle cell lymphoma, small lymphocytic lymphoma, and marginal zone lymphoma biopsies by surface enhanced laser desorption/ionization-time of flight mass spectrometry.
     Leuk Lymphoma. 2011;52:648-58.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
213. ZHANG R , Loughran TP Jr
     Off-target effects of tyrosine kinase inhibitors: Beauty or the Beast?
     Leuk Lymphoma. 2011;52:556-7.
     PubMed     Text format     Related articles   
     
     
     
     March 2011
214. LILIENTHAL N , Prinz C, Peer-Zada AA, Doering M, et al
     Targeting the disturbed redox equilibrium in chronic lymphocytic leukemia by novel reactive oxygen species-catalytic 'sensor/effector' compounds.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
215. BURGER JA , Sivina M, Ravandi F
     The microenvironment in hairy cell leukemia: pathways and potential therapeutic targets.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
216. TACHIBANA T , Numata A, Tanaka M, Motohashi K, et al
     Successful treatment with dasatinib and allogeneic peripheral blood stem cell transplant for imatinib-resistant Philadelphia chromosome-positive acute lymphoblastic leukemia relapsing after bone marrow transplant and donor lymphocyte infusion.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
217. NAGEL S , Venturini L, Przybylski GK, Grabarczyk P, et al
     Activation of Paired-homeobox gene PITX1 by del(5)(q31) in T-cell acute lymphoblastic leukemia.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
218. DASS J , Jain S, Tyagi S, Sazawal S, et al
     Chronic myeloid leukemia with p210 BCR-ABL and monocytosis.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
219. SUMMERS TA , Jaffe ES
     Hairy cell leukemia diagnostic criteria and differential diagnosis.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
220. BALOGH Z , Reiniger L, Rajnai H, Csomor J, et al
     High rate of neoplastic cells with genetic abnormalities in proliferation centers of chronic lymphocytic leukemia.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
221. SHACHAR I , Haran M
     The secret second life of an innocent chaperone: the story of CD74 and B cell/chronic lymphocytic leukemia cell survival.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
222. RAVANDI F
     Chemo-immunotherapy for hairy cell leukemia.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
223. DARDA BAYRAKTAR U , Calzadilla Domingo G, Schmit J, Pereira D, et al
     Azacitidine combined with gemtuzumab ozogamicin in patients with relapsed/refractory acute myeloid leukemia.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
224. SELLNER L , Veldwijk MR, Kleinschmidt JA, Laufs S, et al
     Efficient gene transfer with pseudotyped recombinant adeno-associated viral vectors into human chronic myelogenous leukemia cells.
     Leuk Lymphoma. 2011;52:483-90.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
225. HUBEL K , Weingart O, Naumann F, Bohlius J, et al
     Allogeneic stem cell transplant in adult patients with acute myelogenous leukemia: a systematic analysis of international guidelines and recommendations.
     Leuk Lymphoma. 2011;52:444-57.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
226. OLIVEIRA AC , de la Banda E, Domingo-Domenech E, Encuentra M, et al
     Prospective study of clinical and biological prognostic factors at diagnosis in patients with early stage B-cell chronic lymphocytic leukemia.
     Leuk Lymphoma. 2011;52:429-35.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
227. NABHAN C , Dalal N, Mehta J, Kay NE, et al
     Biologic agent activity in chronic lymphocytic leukemia: a framework for future therapies.
     Leuk Lymphoma. 2011;52:374-86.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
228. FAN C , Xiong Y, Zhu N, Lu Y, et al
     Random small interfering RNA library screen identifies siRNAs that induce human erythroleukemia cell differentiation.
     Leuk Lymphoma. 2011;52:502-14.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     February 2011
229. RAPONI S , Stefania De Propris M, Intoppa S, Laura Milani M, et al
     Flow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
230. GOH HG , Lin M, Fukushima T, Saglio G, et al
     Sensitive quantitation of minimal residual disease in chronic myeloid leukemia using nanofluidic digital polymerase chain reaction assay.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
231. MCCARRON SL , Kelly J, Coen N, McCabe S, et al
     A novel e8a2 BCR-ABL1 fusion with insertion of RALGPS1 exon 8 in a patient with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
232. TAVOR S , Rothman R, Golan T, Voskoboinik N, et al
     Predictive value of TP53 fluorescence in situ hybridization in cytogenetic subgroups of acute myeloid leukemia.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
233. SINISALO M , Sankelo M, Itala-Remes M
     Thrombopoietin receptor agonists can be used temporarily with patients suffering from refractory chronic lymphocytic leukemia-associated immunologic thrombocytopenia.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
234. TADMOR T , Polliack A
     Expanding the use of thrombopoietin mimetic drugs: what about chronic lymphocytic leukemia?
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
235. FAI CHOW K , Sevilla DW, Colovai AI, Bhagat G, et al
     Hematogones are markedly decreased in chronic myeloid leukemia: multiparametric flow cytometric analysis.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
236. VARMA N , Anand MS, Varma S, Juneja SS, et al
     Role of hTERT and WT1 gene expression in disease progression and imatinib responsiveness of patients with BCR-ABL positive chronic myeloid leukemia.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
237. SHIRATORI S , Kondo T, Fujisawa S, Kubota K, et al
     c-myc rearrangement in B-cell lymphoblastic lymphoma with the involvement of multiple extranodal lesions.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
238. 
     Reviewers for Leukemia & Lymphoma during 2010.
     Leuk Lymphoma. 2011;52:345-8.
     PubMed     Text format     Related articles   
     
     
     
     
239. MOHAMMED K , Dignan F, Ethell ME, Davies FE, et al
     An early computed tomography-guided antifungal treatment strategy is safe and efficacious in patients undergoing chemotherapy for high-risk acute leukemia.
     Leuk Lymphoma. 2011;52:339-40.
     PubMed     Text format     Related articles   
     
     
     
     
240. BURBURY K , Chew LP, Westerman D, Catalano A, et al
     Concomitant FIP1L1-PDGFRA fusion gene and T-cell clonality in a case of chronic eosinophilic leukemia with clonal evolution and an incomplete response to imatinib.
     Leuk Lymphoma. 2011;52:335-8.
     PubMed     Text format     Related articles   
     
     
     
     
241. YANG MH , Zhao MY, Wang Z, Kang R, et al
     WAVE1 regulates P-glycoprotein expression via Ezrin in leukemia cells.
     Leuk Lymphoma. 2011;52:298-309.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
242. WANG DM , Miao KR, Fan L, Qiu HR, et al
     Intermediate prognosis of 6q deletion in chronic lymphocytic leukemia.
     Leuk Lymphoma. 2011;52:230-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
243. DELIOUKINA ML , Palmer JM, Thomas SH, Krishnan A, et al
     Allogeneic hematopoietic cell transplant with fludarabine-based reduced-intensity conditioning as treatment for advanced chronic lymphocytic leukemia.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
244. ROTH CG , Contis L, Gupta S, Agha M, et al
     De novo acute myeloid leukemia with Philadelphia chromosome (BCR-ABL) and inversion 16 (CBFB-MYH11): report of two cases and review of the literature.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
245. FULLMER A , Kantarjian H, Cortes J, Jabbour E, et al
     New developments in the treatment of chronic myeloid leukemia and Philadelphia-positive acute lymphoblastic leukemia.
     Leuk Lymphoma. 2011;52 Suppl 1:81-91.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
246. DONATO NJ , Peterson LF
     Chronic myeloid leukemia stem cells and developing therapies.
     Leuk Lymphoma. 2011;52 Suppl 1:60-80.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
247. SKORSKI T
     Chronic myeloid leukemia cells refractory/resistant to tyrosine kinase inhibitors are genetically unstable and may cause relapse and malignant progression to the terminal disease state.
     Leuk Lymphoma. 2011;52 Suppl 1:23-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
248. MITCHELL B , Deininger M
     Techniques for risk stratification of newly diagnosed patients with chronic myeloid leukemia.
     Leuk Lymphoma. 2011;52 Suppl 1:4-11.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
249. REDIG AJ , Vakana E, Platanias LC
     Regulation of mammalian target of rapamycin and mitogen activated protein kinase pathways by BCR-ABL.
     Leuk Lymphoma. 2011;52 Suppl 1:45-53.
     PubMed     Text format     Related articles   
     
     
     
     
250. PERROTTI D , Harb JG
     BCR-ABL1 kinase-dependent alteration of mRNA metabolism: potential alternatives for therapeutic intervention.
     Leuk Lymphoma. 2011;52 Suppl 1:30-44.
     PubMed     Text format     Related articles   
     
     
     
     
251. DIAMOND JM , Melo JV
     Mechanisms of resistance to BCR-ABL kinase inhibitors.
     Leuk Lymphoma. 2011;52 Suppl 1:12-22.
     PubMed     Text format     Related articles   
     
     
     
     
252. KERBAUY FR , Rodrigues M, de Souza Santos FP, Sobrinho JN, et al
     Allogeneic hematopoietic stem cell transplant after intravenous busulfan and fludarabine conditioning.
     Leuk Lymphoma. 2011;52:321-4.
     PubMed     Text format     Related articles   
     
     
     
     
253. VAN DEN BERG H
     Asparaginase revisited.
     Leuk Lymphoma. 2011;52:168-78.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
254. LIU H , Artz AS
     Reduction of imatinib absorption after gastric bypass surgery.
     Leuk Lymphoma. 2011;52:310-3.
     PubMed     Text format     Related articles   
     
     
     
     January 2011
255. RYEON LEE S , Lee SY, Nam MH, Park Y, et al
     Successful control of steroid-intolerant Evans' syndrome associated with allogeneic peripheral blood hematopoietic stem cell transplant by rituximab.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
256. POWERS JJ , Dubovsky JA, Epling-Burnette PK, Moscinski L, et al
     A molecular and functional analysis of large granular lymphocyte expansions in patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
257. SABA NS , Levy LS
     Apoptotic induction in B-cell acute lymphoblastic leukemia cell lines treated with a protein kinase C inhibito.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
258. DREYLING M , Polliack A, Tadmor T
     Chlorambucil in indolent mantle cell lymphoma - just another old drug for a new disease?
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
259. VALENT P , Sotlar K, Horny HP
     Aberrant expression of CD30 in aggressive systemic mastocytosis and mast cell leukemia: a differential diagnosis to consider in aggressive hematopoietic CD30-positive neoplasms.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
260. NAGEL S , Venturini L, Meyer C, Kaufmann M, et al
     Transcriptional deregulation of oncogenic myocyte enhancer factor 2C in T-cell acute lymphoblastic leukemia.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
261. FUJITA N , Kobayashi R, Takimoto T, Nakagawa A, et al
     Results of the Japan Association of Childhood Leukemia Study (JACLS) NHL-98 protocol for the treatment of B-cell non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia in childhood.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
262. CALABRETTA B , Salomoni P
     Inhibition of autophagy: a new strategy to enhance sensitivity of chronic myeloid leukemia stem cells to tyrosine kinase inhibitors.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
263. PLATANIAS LC
     A special issue: Mechanisms of BCR-ABL leukemogenesis and novel targets for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
264. KERN W , Bacher U, Haferlach C, Schnittger S, et al
     Acute monoblastic/monocytic leukemia and chronic myelomonocytic leukemia share common immunophenotypic features but differ in the extent of aberrantly expressed antigens and amount of granulocytic cells.
     Leuk Lymphoma. 2011;52:92-100.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
265. LINGARATNAM S , Thursky KA, Slavin MA
     Fluoroquinolone prophylaxis: a word of caution.
     Leuk Lymphoma. 2011;52:5-6.
     PubMed     Text format     Related articles   
     
     
     
     
266. NG ES , Liew Y, Earnest A, Koh LP, et al
     Audit of fluoroquinolone prophylaxis against chemotherapy-induced febrile neutropenia in a hospital with highly prevalent fluoroquinolone resistance.
     Leuk Lymphoma. 2011;52:131-3.
     PubMed     Text format     Related articles   
     
     
     
     December 2010
267. D'ARENA G , Cascavilla N
     Romiplostim for chronic lymphocytic leukemia-associated immune thrombocytopenia.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
268. YEUNG DT , White DL
     Imatinib trough levels in chronic myelogenous leukemia: does one dose fit all?
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
269. KAJIWARA R , Goto H, Tanoshima R, Kato H, et al
     Myeloperoxidase-positive acute leukemia with precursor B cell immunophenotype.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
270. MULAY S , Bauer F, Boruchov A, Bilgrami S, et al
     Successful resolution of acute myelogenous leukemia-associated hemophagocytic lymphohistiocytosis with decitabine.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
271. YI S , Yu Z, Zhou K, Wang Y, et al
     TOSO is overexpressed and correlated with disease progression in Chinese patients with chronic lymphocytic leukemia.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
272. FORCONI F , Cencini E, Sicuranza A, Sozzi E, et al
     Molecular insight into the biology and clinical course of hairy cell leukemia utilizing immunoglobulin gene analysis.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
273. HANCER VS , Kose M, Diz-Kucukkaya R, Yavuz AS, et al
     Activation-induced cytidine deaminase mRNA levels in chronic lymphocytic leukemia.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
274. RACIL Z , Razga F, Polakova KM, Buresova L, et al
     Assessment of adenosine triphosphate-binding cassette subfamily B member 1 (ABCB1) mRNA expression in patients with de novo chronic myelogenous leukemia: the role of different cell types.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
275. TER ELST A , Diks SH, Kampen KR, Hoogerbrugge PM, et al
     Identification of new possible targets for leukemia treatment by kinase activity profiling.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
276. KIM TD , Schwarz M, Kreuzer KA, Kaeda J, et al
     Long-term follow-up of patients with Philadelphia chromosome-positive chronic myeloid leukemia after stem cell mobilization under imatinib.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
277. MORRIS K , Weston H, Mollee P, Marlton P, et al
     Outcome of treatment of adult acute lymphoblastic leukemia with hyperfractionated cyclophosphamide, doxorubicin, vincristine, dexamethasone/methotrexate, cytarabine: results from an Australian population.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     November 2010
278. HOFMANN BT , Hoxha E, Mohr E, Schulz K, et al
     Posttranscriptional regulation of the p85alpha.alpha; adapter subunit of phosphatidylinositol 3-kinase in human leukemia cells.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
279. FABIANI E , Leone G, Giachelia M, D'alo' F, et al
     Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
280. PICCALUGA PP , Arpinati M, Candoni A, Laterza C, et al
     Surface antigens analysis reveals significant expression of candidate targets for immunotherapy in adult acute lymphoid leukemia.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
281. MAEDA Y , Sasakawa A, Hirase C, Yamaguchi T, et al
     Senescence induction therapy for the treatment of adult T-cell leukemia.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
282. TOMOMATSU J , Isobe Y, Oshimi K, Tabe Y, et al
     Chronic lymphocytic leukemia in a Japanese population: varied immunophenotypic profile, distinctive usage of frequently mutated IGH gene, and indolent clinical behavior.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
283. RUIZ-DELGADO GJ , Macias-Gallardo J, Lutz-Presno JA, Montes-Montiel M, et al
     Outcome of adults with acute lymphoblastic leukemia treated with a pediatric-inspired therapy: a single institution experience.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
284. ATHANASIADOU A , Stalika E, Sidi V, Papaioannou M, et al
     RUNX1-MTG16 fusion gene in de novo acute myeloblastic leukemia with t(16;21)(q24;q22).
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
285. SHANAFELT T , Zent C, Byrd J, Erlichman C, et al
     Phase II trials of single-agent anti-VEGF therapy for patients with chronic lymphocytic leukemia.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
286. LARSON SM , Godley LA
     Getting to the root of the stem cell in mutated chronic myeloid leukemia.
     Leuk Lymphoma. 2010;51:2147-8.
     PubMed     Text format     Related articles   
     
     
     
     
287. CARNEY DA , Seymour JF
     Therapy-related myelodysplasia and fludarabine combination therapy - do the benefits justify the risk?
     Leuk Lymphoma. 2010;51:1957-9.
     PubMed     Text format     Related articles   
     
     
     
     
288. BHATTA S , Kut V, Petronic-Rosic V, Hyjek E, et al
     Therapy-related myeloid sarcoma with an NPM1 mutation.
     Leuk Lymphoma. 2010;51:2130-1.
     PubMed     Text format     Related articles   
     
     
     
     October 2010
289. KLIMEK VM , Tallman MS
     Hypomethylating agents in acute lymphoblastic leukemia: untapped potential?
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
290. CHANG ST , Hsieh YC, Chen CH, Tsao CJ, et al
     T-cell large granular lymphocytic leukemia with pleomorphic nuclei and colonic infiltration with chronic diarrhea.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
291. BRAOUDAKI M , Tsangaris GT, Karamolegou K, Anagnostopoulos AK, et al
     Proteomic profile of a therapy related acute myeloid leukemia following brain tumor.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
292. CHOMEL JC , Sorel N, Bonnet ML, Bertrand A, et al
     Extensive analysis of the T315I substitution and detection of additional ABL mutations in progenitors and primitive stem cell compartment in a patient with tyrosine kinase inhibitor-resistant chronic myeloid leukemia.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
293. IASTREBNER M , Jang JH, Nucifora E, Kim K, et al
     Decitabine in myelodysplastic syndromes and chronic myelomonocytic leukemia: Argentinian/South Korean multi-institutional clinical experience.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
294. JEZISKOVA I , Razga F, Bajerova M, Racil Z, et al
     IDH2 mutations in patients with acute myeloid leukemia: missense p.R140 mutations are linked to disease status.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
295. XU XJ , Tang YM, Song H, Yang SL, et al
     Long-term outcome of childhood acute myeloid leukemia in a developing country: experience from a children's hospital in China.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
296. BIANCHI S , Moreno P, Landoni AI, Naya H, et al
     Immunoglobulin heavy chain V-D-J gene rearrangement and mutational status in Uruguayan patients with chronic lymphocytic leukemia.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
297. LIAPIS K , Apostolidis I, Karmiris T, Harhalakis N, et al
     Numb chin syndrome as the initial manifestation of acute megakaryoblastic leukemia.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
298. EKLUND EA , Raychaudhuri P, Platanias LC
     Correlation between IDH2 mutations and disease status in acute myeloid leukemia.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
299. FRIEDMAN DR , Magura LA, Warren HA, Harrison JD, et al
     Statin use and need for therapy in chronic lymphocytic leukemia.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
300. VIJAYAKRISHNAN J , Sherborne AL, Sawangpanich R, Hongeng S, et al
     Variation at 7p12.2 and 10q21.2 influences childhood acute lymphoblastic leukemia risk in the Thai population and may contribute to racial differences in leukemia incidence.
     Leuk Lymphoma. 2010;51:1870-4.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
301. REISS C , Haneke T, Volker HU, Spahn M, et al
     Conditional inactivation of MLH1 in thymic and naive T-cells in mice leads to a limited incidence of lymphoblastic T-cell lymphomas.
     Leuk Lymphoma. 2010;51:1875-86.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
302. BELCHEVA A , Kolaj B, Martin A
     Missing mismatch repair: a key to T cell immortality.
     Leuk Lymphoma. 2010;51:1777-8.
     PubMed     Text format     Related articles   
     
     
     
     
303. CHURPEK JE , Garcia JS, Madzo J, Jackson SA, et al
     Identification and molecular characterization of a novel 3′ mutation in RUNX1 in a family with familial platelet disorder.
     Leuk Lymphoma. 2010;51:1931-5.
     PubMed     Text format     Related articles   
     
     
     
     September 2010
304. SUGANUMA K , Miwa H, Imai N, Shikami M, et al
     Energy metabolism of leukemia cells: glycolysis versus oxidative phosphorylation.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
305. PAULSON K , Kumar R, Ahsanuddin A, Seftel MD, et al
     Azacytidine as a novel agent in the treatment of acute lymphoblastic leukemia.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
306. ZENT CS
     Cell-mediated immunity in chronic lymphocytic leukemia.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
307. SATAKE A , Okada M, Asada T, Fujita K, et al
     Dasatinib is effective against optic nerve infiltration of Philadelphia chromosome-positive acute lymphoblastic leukemia.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
308. MU Q , Cheng Y, Xu W, Wang Y, et al
     Acquired Robertsonian translocation is not always suggestive of poor prognosis: a case of acquired Rob(13;14) in Philadelphia chromosome-negative cells of chronic myelogenous leukemia.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
309. MACDONALD DH , Clark I, Naresh KN
     The Hammersmith Hospital hematopathology case of the month: paraspinal B lymphoblastic lymphoma - problems in diagnosis and initial indolent behavior.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
310. MEDHI K , Raina V, Kumar L, Sharma A, et al
     Response assessment of patients with chronic myeloid leukemia receiving imatinib mesylate (Glivec) therapy: experience from a single center in a developing country.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
311. MIYAWAKI S , Hatsumi N, Tamaki T, Naoe T, et al
     Prognostic potential of detection of WT1 mRNA level in peripheral blood in adult acute myeloid leukemia.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
312. STAHL T , Badbaran A, Kroger N, Klyuchnikov E, et al
     Minimal residual disease diagnostics in patients with acute myeloid leukemia in the post-transplant period: comparison of peripheral blood and bone marrow analysis.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
313. GONZALEZ-RODRIGUEZ AP , Contesti J, Huergo-Zapico L, Lopez-Soto A, et al
     Prognostic significance of CD8 and CD4 T cells in chronic lymphocytic leukemia.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
314. LAI TY , Yang JS, Wu PP, Huang WW, et al
     The quinolone derivative CHM-1 inhibits murine WEHI-3 leukemia in BALB/c mice in vivo.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
315. NIPARUCK P , Kanoksil W, Chuncharunee S, Boonsakan P, et al
     Therapy-related myelodysplastic syndrome/acute myeloid leukemia following fludarabine therapy for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Thai patients.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
316. FORMANKOVA R , Sedlacek P, Keslova P, Sramkova L, et al
     Adoptive immunotherapy, chemotherapy, and second allogeneic transplant in the treatment of post-transplant relapse of acute leukemia in children: a single center experience.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
317. WANG E , Stoecker M
     "Cannibalistic" phagocytosis in acute megakaryoblastic leukemia (AML M7) with t(10;17)(p15;q22).
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
318. WONG WS , Liu BW, Lam FS, Wong KF, et al
     ALK-negative anaplastic large cell lymphoma in leukemic phase with near-pentaploidy.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
319. GRIFFITHS EA , Gore SD, Hooker C, McDevitt MA, et al
     Acute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylation.
     Leuk Lymphoma. 2010;51:1711-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     August 2010
320. PERIARD D
     Peripherally inserted central catheter in leukemia: insertion site determines clotting risk.
     Leuk Lymphoma. 2010;51:1391-2.
     PubMed     Text format     Related articles   
     
     
     
     
321. PATZ M , Pallasch CP, Wendtner CM
     Critical role of microRNAs in chronic lymphocytic leukemia: overexpression of the oncogene PLAG1 by deregulated miRNAs.
     Leuk Lymphoma. 2010;51:1379-81.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
322. POPAL W , Boucas J, Peer-Zada AA, Herling M, et al
     Pharmacologic interception in T-cell leukemia 1A associated pathways as a treatment rationale for chronic lymphocytic leukemia.
     Leuk Lymphoma. 2010;51:1375-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
323. SCIELZO C , Ten Hacken E, Bertilaccio MT, Muzio M, et al
     How the microenvironment shapes chronic lymphocytic leukemia: the cytoskeleton connection.
     Leuk Lymphoma. 2010;51:1371-4.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
324. LANASA MC , Allgood SD, Weinberg JB
     Monoclonal B cell lymphocytosis.
     Leuk Lymphoma. 2010;51:1386-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
325. OBAMA K , Makishima H, Ishida F
     Killer cell immunoglobulin-like receptor gene polymorphism in lymphoproliferative diseases of granular lymphocytes in a Japanese population.
     Leuk Lymphoma. 2010;51:1580-1.
     PubMed     Text format     Related articles   
     
     
     
     
326. SHOUVAL R , Duffield A, Gocke C, Lee L, et al
     Pentostatin-induced hypereosinophilia with eosinophilic gastroenteritis.
     Leuk Lymphoma. 2010;51:1567-9.
     PubMed     Text format     Related articles   
     
     
     
     July 2010
327. BASHIR Q , De Lima MJ, McMannis JD, Garcia-Manero G, et al
     Hematopoietic progenitor cell collection in patients with chronic myelogenous leukemia in complete cytogenetic remission after imatinib mesylate therapy.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
328. SIDERS WM , Shields J, Garron C, Hu Y, et al
     Involvement of neutrophils and natural killer cells in the anti-tumor activity of alemtuzumab in xenograft tumor models.
     Leuk Lymphoma. 2010;51:1293-304.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     June 2010
329. CAVATTONI I , Ayuk F, Zander AR, Zabelina T, et al
     Diagnosis of Toxoplasma gondii infection after allogeneic stem cell transplant can be difficult and requires intensive scrutiny.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
330. NARESH KN , Zokaie S, Madhavan KS, Chu A, et al
     The Hammersmith Hospital hematopathology case of the month: myeloid sarcoma with Langerhans cell proliferation.
     Leuk Lymphoma. 2010;51:1128-34.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
331. YU W , Sun X, Tang H, Tao Y, et al
     Inhibition of class II phosphoinositide 3-kinase gamma expression by p185(Bcr-Abl) contributes to impaired chemotaxis and aberrant homing of leukemic cells.
     Leuk Lymphoma. 2010;51:1098-107.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
332. CZUCZMAN MS , Gregory SA
     The future of CD20 monoclonal antibody therapy in B-cell malignancies.
     Leuk Lymphoma. 2010;51:983-94.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
333. SHARMA P , Mohanty S, Kochupillai V, Kumar L, et al
     Mutations in ABL kinase domain are associated with inferior progression-free survival.
     Leuk Lymphoma. 2010;51:1072-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     May 2010
334. KIM MK , Cho HS, Bae YK, Lee KH, et al
     Therapy-related myeloid neoplasm in a patient with TP53 mutation: a dilemma in allogeneic stem cell transplant.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
335. TIU RV , Singh AD, Workman J, Cotta CV, et al
     Concomitant conjunctival mucosa-associated lymphoid tissue lymphoma and small lymphocytic lymphoma associated with immunoglobulin M macroglobulinemia successfully treated with intensity modulated radiation therapy.
     Leuk Lymphoma. 2010;51:952-5.
     PubMed     Text format     Related articles   
     
     
     
     April 2010
336. BRUCHOVA-VOTAVOVA H , Yoon D, Prchal JT
     miR-451 enhances erythroid differentiation in K562 cells.
     Leuk Lymphoma. 2010;51:686-93.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
337. TEFFERI A
     Mutational analysis in BCR-ABL-negative classic myeloproliferative neoplasms: impact on prognosis and therapeutic choices.
     Leuk Lymphoma. 2010;51:576-82.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
338. HU H , Li Y, Gu J, Zhu X, et al
     Antisense oligonucleotide against miR-21 inhibits migration and induces apoptosis in leukemic K562 cells.
     Leuk Lymphoma. 2010;51:694-701.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     March 2010
339. MOLICA S
     A systematic review on Richter syndrome: what is the published evidence?
     Leuk Lymphoma. 2010;51:415-21.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
340. FUNG KL , Liang RH, Chan GC
     Vincristine but not imatinib could suppress mesenchymal niche's support to lymphoid leukemic cells.
     Leuk Lymphoma. 2010;51:515-22.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
341. JAYASEKARA H , Karahalios A, Juneja S, Thursfield V, et al
     Incidence and survival of lymphohematopoietic neoplasms according to the World Health Organization classification: a population-based study from the Victorian Cancer Registry in Australia.
     Leuk Lymphoma. 2010;51:456-68.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     February 2010
342. CLOONAN SM , Drozgowska A, Fayne D, Williams DC, et al
     The antidepressants maprotiline and fluoxetine have potent selective antiproliferative effects against Burkitt lymphoma independently of the norepinephrine and serotonin transporters.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     December 2009
343. BRACCI PM , Skibola CF, Conde L, Halperin E, et al
     Chemokine polymorphisms and lymphoma: a pooled analysis.
     Leuk Lymphoma. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: